Clinical Feature of Men Who Benefit from Dose Escalation of Naftopidil for Lower Urinary Tract Symptoms: A Prospective Study

Objectives. To examine the feature of men who benefit from dose escalation of naftopidil for lower urinary tract symptoms (LUTSs). Methods. Based on the IPSS, men reporting LUTS were prospectively studied using 50 mg/day of naftopidil for the first 4 weeks; satisfied patients continued its 50 mg/day...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizusawa, Takaki, Hara, Noboru, Obara, Kenji, Isahaya, Etsuko, Nakagawa, Yuki, Takahashi, Kota
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095445/
https://www.ncbi.nlm.nih.gov/pubmed/21603217
http://dx.doi.org/10.1155/2011/804583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095445/
https://www.ncbi.nlm.nih.gov/pubmed/21603217
http://dx.doi.org/10.1155/2011/804583

Ejemplares similares